EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial

Seong-Beom Park iD, Suryaprakash Mishra iD, Sang-Kyu Shin iD, Stebin Xavier iD, Giulia Zigon iD, Manuel Zocco iD, Marie Van Der Wielen iD, Dong-Gun Lee iD, AReSVi-006 study group

Infection & Chemotherapy · 2026 · 58 (3) · 332

DOI: 10.3947/ic.2026.0016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection & Chemotherapy, 2026. Verfasst von Seong-Beom Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Seoul, Korea. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HumanRespiratory syncytial virusRespiratory syncytial virus vaccineSafetyVaccine preventable diseases

Autor:innen und Institutionen

  • GSK, Seoul, Korea.
  • GSK Asia House, Singapore.
  • GSK, Bangalore, India.
  • GSK, Siena, Italy.
  • GSK, Wavre, Belgium.
  • Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. symonlee@catholic.ac.kr.

ORCID-Profile: Seong-Beom Park, Suryaprakash Mishra, Sang-Kyu Shin, Stebin Xavier, Giulia Zigon, Manuel Zocco, Marie Van Der Wielen, Dong-Gun Lee

Förderung

  • GSK

Zitieren

APA

Park, S. B., Mishra, S., Shin, S. K., Xavier, S., Zigon, G., Zocco, M., Van Der Wielen, M., Lee, D. G., & AReSVi-006 study group (2026). Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial. Infection & Chemotherapy, 58(3), 332. https://doi.org/10.3947/ic.2026.0016

Vancouver

Park SB, Mishra S, Shin SK, Xavier S, Zigon G, Zocco M, et al. Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial. Infection & Chemotherapy. 2026;58(3):332. doi:10.3947/ic.2026.0016

BibTeX
@article{Park2026,
  author = {Park, Seong-Beom and Mishra, Suryaprakash and Shin, Sang-Kyu and Xavier, Stebin and Zigon, Giulia and Zocco, Manuel and Van Der Wielen, Marie and Lee, Dong-Gun and AReSVi-006 study group, AReSVi-006 study group},
  title = {Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial},
  journal = {Infection & Chemotherapy},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {332},
  doi = {10.3947/ic.2026.0016}
}
Kostenlos starten →